|
0 members (),
158
guests, and
25
robots. |
Key:
Admin,
Global Mod,
Mod
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
There are no members with birthdays on this day. |
#456436
Tue 17 Apr 2018 03:57:PM
|
Joined: Feb 2001
Posts: 381,903
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,903 |
Chronic lymphocytic leukemia (CLL) is a hematological malignancy. When infiltrating tissues, CLL cells come in contact with healthy cells, including immune cells. Researchers have now characterized the composition of immune cells and circulating cytokines of the CLL microenvironment in mouse models using mass cytometry. Based on this knowledge, they propose an immunotherapeutic strategy with two immune checkpoint inhibitors that efficiently blocks disease development in preclinical tests. Source: Efficient control of leukemia with treatment by dual immune-checkpoint blockade
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
Entire Thread
|
Efficient control of leukemia with treatment by dual immune-checkpoint blockade
|
Webmaster
|
Tue 17 Apr 2018 03:57:PM
|
Forums60
Topics687,219
Posts721,830
Members2,957
|
Most Online3,142 Jan 16th, 2023
|
|
|
|
Copyright 1996 - 2023 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|